Following regulatory approval of Alison Platt, the Board of Hargreaves Lansdown announces her appointment to role of Chair of the Board and as a Non-Executive Director of HL with effect from February 6, 2024.
Alison Platt has extensive leadership experience across both private and listed companies in the healthcare, financial services, retail and property, and regulated sectors. She currently holds Chair positions at Dechra Pharmaceuticals, a FTSE100 specialist veterinary products business, and insurance company Ageas UK. She has also been a Non-Executive Director of Tesco Plc since 2016.
Ms Platt was CEO of Countrywide from 2014 – 2018 and prior to that she held several senior roles at BUPA, including as Managing Director of its International Development Markets business. She was previously a Non-executive director of the Foreign and Commonwealth Office, a member of Hampton-Alexander review steering group advising on diversity and inclusion and Chair of Opportunity Now.
